Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097331
Status:
COMPLETED
Last Update Posted:
2015-04-13
First Post:
2004-11-22
Brief Title:
Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline